The company has rolled Zignyl into a new product called Zippy, an AI-powered data dashboard that operators can talk to like a chatbot.
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.